Ron Laufer - Net Worth and Insider Trading
Ron Laufer Net Worth
The estimated net worth of Ron Laufer is at least $336,056 dollars as of 2024-09-20. Ron Laufer is the Director, 10% Owner of Astria Therapeutics Inc and owns about 27,211 shares of Astria Therapeutics Inc (ATXS) stock worth over $336,056. Details can be seen in Ron Laufer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ron Laufer has not made any transactions after 2015-06-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ron Laufer
Ron Laufer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ron Laufer owns 1 companies in total, including Astria Therapeutics Inc (ATXS) .
Click here to see the complete history of Ron Laufer’s form 4 insider trades.
Insider Ownership Summary of Ron Laufer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATXS | Astria Therapeutics Inc | 2015-06-30 | director & 10 percent owner |
Ron Laufer Latest Holdings Summary
Ron Laufer currently owns a total of 1 stock. Ron Laufer owns 27,211 shares of Astria Therapeutics Inc (ATXS) as of June 30, 2015, with a value of $336,056.
Latest Holdings of Ron Laufer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATXS | Astria Therapeutics Inc | 2015-06-30 | 27,211 | 12.35 | 336,056 |
Holding Weightings of Ron Laufer
Ron Laufer Form 4 Trading Tracker
According to the SEC Form 4 filings, Ron Laufer has made a total of 0 transactions in Astria Therapeutics Inc (ATXS) over the past 5 years. The most-recent trade in Astria Therapeutics Inc is the acquisition of 3,724 shares on June 30, 2015, which cost Ron Laufer around $3 Million.
Insider Trading History of Ron Laufer
- 1
Ron Laufer Trading Performance
GuruFocus tracks the stock performance after each of Ron Laufer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ron Laufer is -33.74%. GuruFocus also compares Ron Laufer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ron Laufer within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ron Laufer's insider trading performs compared to the benchmark.
Performance of Ron Laufer
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.33 | | | | | |
| Relative Return to S&P 500(%) | 12.12 | | | | | |
Ron Laufer Ownership Network
Ron Laufer Owned Company Details
What does Astria Therapeutics Inc do?
Who are the key executives at Astria Therapeutics Inc?
Ron Laufer is the director & 10 percent owner of Astria Therapeutics Inc. Other key executives at Astria Therapeutics Inc include Chief Medical Officer Christopher Morabito , director & 10 percent owner Perceptive Life Sciences Master Fund Ltd , and Chief Business Officer Andrea Matthews .
Astria Therapeutics Inc (ATXS) Insider Trades Summary
Over the past 18 months, Ron Laufer made no insider transaction in Astria Therapeutics Inc (ATXS). Other recent insider transactions involving Astria Therapeutics Inc (ATXS) include a net purchase of 4,295,958 shares made by Perceptive Life Sciences Master Fund Ltd , and a net sale of 20,000 shares made by Christopher Morabito .
In summary, during the past 3 months, insiders sold 0 shares of Astria Therapeutics Inc (ATXS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 20,000 shares of Astria Therapeutics Inc (ATXS) were sold and 4,295,958 shares were bought by its insiders, resulting in a net purchase of 4,275,958 shares.
Astria Therapeutics Inc (ATXS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Astria Therapeutics Inc Insider Transactions
Ron Laufer Mailing Address
Above is the net worth, insider trading, and ownership report for Ron Laufer. You might contact Ron Laufer via mailing address: C/o Catabasis Pharmaceuticals, Inc., One Kendall Sq., Bldg. 1400e, Ste B14202, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
